Showing 1 - 20 results of 107,016 for search '(( 50 mg decrease ) OR ( 1_ ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.38s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    Subjects:
  5. 5
  6. 6
  7. 7

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
  8. 8

    Dynorphin Neuropeptides Decrease Apparent Proton Affinity of ASIC1a by Occluding the Acidic Pocket by Lilia Leisle (11356934)

    Published 2021
    “…Covalently tethering Big Dyn to its ASIC1a binding site dramatically decreased the proton sensitivity of channel activation, suggesting that Big Dyn stabilizes a resting conformation of ASIC1a and dissociates from its binding site during channel opening.…”
  9. 9

    Dynorphin Neuropeptides Decrease Apparent Proton Affinity of ASIC1a by Occluding the Acidic Pocket by Lilia Leisle (11356934)

    Published 2021
    “…Covalently tethering Big Dyn to its ASIC1a binding site dramatically decreased the proton sensitivity of channel activation, suggesting that Big Dyn stabilizes a resting conformation of ASIC1a and dissociates from its binding site during channel opening.…”
  10. 10

    Image_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.tif by Zijing Ran (11429935)

    Published 2021
    “…Subjects included had all been treated with urate-lowering therapy (ULT) (febuxostat 20–80 mg/day or benzbromarone 25–50 mg/day, validated by the medical record). …”
  11. 11

    DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

    Published 2021
    “…Subjects included had all been treated with urate-lowering therapy (ULT) (febuxostat 20–80 mg/day or benzbromarone 25–50 mg/day, validated by the medical record). …”
  12. 12
  13. 13
  14. 14
  15. 15

    Sleep is decreased in TBI survivors. by Bart van Alphen (12003724)

    Published 2022
    “…Sleep data for survivors is shown here. <b>(A1–3)</b> Total sleep during the day, night and total sleep shows that post-TBI is mostly decreased during the night, for up to 4 days post TBI. …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20